Sabra Health Care Financial Statements (SBRA)
|
|
|
|
Report date
|
|
|
30.03.2022 |
31.12.2022 |
21.02.2023 |
20.03.2023 |
27.02.2024 |
|
31.10.2024 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
569.5 |
624.8 |
624.8 |
624.8 |
655.8 |
|
609.7 |
|
Operating Income, bln rub |
|
|
19.0 |
234.7 |
135.6 |
135.6 |
218.6 |
|
200.2 |
|
EBITDA, bln rub |
? |
|
198.0 |
216.9 |
323.4 |
323.4 |
418.2 |
|
431.7 |
|
Net profit, bln rub |
? |
|
-113.3 |
-77.6 |
-77.6 |
-77.6 |
13.8 |
|
97.2 |
|
|
OCF, bln rub |
? |
|
356.4 |
315.7 |
315.7 |
315.7 |
300.6 |
|
309.3 |
|
CAPEX, bln rub |
? |
|
33.6 |
0.000 |
0.000 |
0.000 |
0.000 |
|
5.27 |
|
FCF, bln rub |
? |
|
322.8 |
315.7 |
315.7 |
315.7 |
300.6 |
|
314.6 |
|
Dividend payout, bln rub
|
|
|
262.9 |
277.2 |
277.2 |
277.2 |
277.4 |
|
278.5 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
2 017% |
|
286.6% |
|
|
OPEX, bln rub |
|
|
217.6 |
227.5 |
227.5 |
227.5 |
42.4 |
|
83.0 |
|
Cost of production, bln rub |
|
|
141.2 |
162.6 |
162.6 |
162.6 |
378.3 |
|
334.6 |
|
R&D, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Interest expenses, bln rub |
|
|
98.6 |
105.5 |
105.5 |
105.5 |
113.0 |
|
130.7 |
|
|
Assets, bln rub |
|
|
5 967 |
5 748 |
5 748 |
5 748 |
5 386 |
|
5 366 |
|
Net Assets, bln rub |
? |
|
3 380 |
3 056 |
3 056 |
3 056 |
2 803 |
|
2 745 |
|
Debt, bln rub |
|
|
2 394 |
2 507 |
2 704 |
2 704 |
2 447 |
|
2 498 |
|
Cash, bln rub |
|
|
112.0 |
49.3 |
49.3 |
49.3 |
46.7 |
|
63.0 |
|
Net debt, bln rub |
|
|
2 282 |
2 457 |
2 654 |
2 654 |
2 400 |
|
2 435 |
|
|
Ordinary share price, rub |
|
|
13.5 |
12.4 |
12.4 |
12.4 |
14.3 |
|
14.2 |
|
Number of ordinary shares, mln |
|
|
219.1 |
230.9 |
230.9 |
230.9 |
231.2 |
|
234.3 |
|
|
Market cap, bln rub |
|
|
2 966 |
2 871 |
2 871 |
2 871 |
3 299 |
|
3 334 |
|
EV, bln rub |
? |
|
5 249 |
5 328 |
5 525 |
5 525 |
5 699 |
|
5 769 |
|
Book value, bln rub |
|
|
3 325 |
3 016 |
3 016 |
3 016 |
2 772 |
|
2 716 |
|
|
EPS, rub |
? |
|
-0.52 |
-0.34 |
-0.34 |
-0.34 |
0.06 |
|
0.41 |
|
FCF/share, rub |
|
|
1.47 |
1.37 |
1.37 |
1.37 |
1.30 |
|
1.34 |
|
BV/share, rub |
|
|
15.2 |
13.1 |
13.1 |
13.1 |
12.0 |
|
11.6 |
|
|
EBITDA margin, % |
? |
|
34.8% |
34.7% |
51.8% |
51.8% |
63.8% |
|
70.8% |
|
Net margin, % |
? |
|
-19.9% |
-12.4% |
-12.4% |
-12.4% |
2.10% |
|
15.9% |
|
FCF yield, % |
? |
|
10.9% |
11.0% |
11.0% |
11.0% |
9.11% |
|
9.44% |
|
ROE, % |
? |
|
-3.35% |
-2.54% |
-2.54% |
-2.54% |
0.49% |
|
3.54% |
|
ROA, % |
? |
|
-1.90% |
-1.35% |
-1.35% |
-1.35% |
0.26% |
|
1.81% |
|
|
P/E |
? |
|
-26.2 |
-37.0 |
-37.0 |
-37.0 |
239.8 |
|
34.3 |
|
P/FCF |
|
|
9.19 |
9.09 |
9.09 |
9.09 |
11.0 |
|
10.6 |
|
P/S |
? |
|
5.21 |
4.59 |
4.59 |
4.59 |
5.03 |
|
5.47 |
|
P/BV |
? |
|
0.89 |
0.95 |
0.95 |
0.95 |
1.19 |
|
1.23 |
|
EV/EBITDA |
? |
|
26.5 |
24.6 |
17.1 |
17.1 |
13.6 |
|
13.4 |
|
Debt/EBITDA |
|
|
11.5 |
11.3 |
8.21 |
8.21 |
5.74 |
|
5.64 |
|
|
R&D/CAPEX, % |
|
|
0.00% |
|
|
|
|
|
0 |
|
|
CAPEX/Revenue, % |
|
|
5.90% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.86% |
|
| Sabra Health Care shareholders |
